Investing.com - Avid Bioservices reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Avid Bioservices announced earnings per share of $0.02 on revenue of $36.7M. Analysts polled by Investing.com EPS of $0.04 on revenue of $33.44M.
Avid Bioservices 's are down 45% and is trading at $15.96 , still down 53.75% from its 52 week high of $34.51 set on Thursday, November 11, 2021.
Avid Bioservices follows other major Healthcare sector earnings this month
Avid Bioservices's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, EPS of $1.12 on revenue of $7.22B.
Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of $1.34 on revenue of $1.72B, for EPS of $1.2 on revenue of $1.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar